Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week
Intuitive Surgical, Inc. heads into the Christmas-shortened trading week with momentum—yet also with two developments investors will likely keep on the radar: a newly posted FDA Class 2 recall entry tied to a da Vinci 5 console component, and a recent FDA clearance that expands da Vinci SP into three high-volume general surgery procedures.
